ADDvise Group’s nomination committee for the annual general meeting 2020

21-01-2020   Non-regulatory press release

In accordance with the resolution at the 2019 annual general meeting of ADDvise Group AB the nomination committee for the annual general meeting 2020 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register maintained by Euroclear Sweden as of 31 August 2019 and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee.

The nomination committee has now been appointed and comprises the following members:

  • Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership
  • Per Åhlgren, shareholder through indirect ownership
  • Magnus Vahlquist, shareholder through direct and indirect ownership
  • Meg Tivéus, chairman ADDvise Group AB

The nomination committee shall prepare proposals for the 2020 annual general meeting regarding appointment of chairman of the meeting, chairman of the board of directors and other directors of the board and remuneration to the directors of the board and to the auditor.

Shareholders, who wish to present proposals to the nomination committee for the 2020 annual general meeting can submit them by post: ADDvise Group AB, att: Nomination Committee, Grev Turegatan 3, SE-114 46 Stockholm.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.       

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected

Regulatory

The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million

Regulatory

ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…